Objective:The study aimed to determine what proportion of Turkiye's preoperative patient population has tested positive for COVID-19 and to ascertain whether the increasing or decreasing trend in the numbers of positive preoperative patients resembles the general population of Turkiye during the same period.
Materials and Methods:The study cohort involved of the 14,776 patients from various services between January 1-December 31, 2021 who needed preoperative COVID-19 test reports. The patient's SARS-CoV-2 RNA's were detected with real-time polymerase chain reaction (RT-PCR) technique.Results: SARS-CoV-2 RT-PCR positivity was detected in 422 (2.86%) patients, of which 59.72% (n = 252) were female and 40.28% (n = 170) were male; their mean age was 40.2 years. Of the 422 positive cases, 84.12% were young adults (18-65 years), and 9% were middle-aged (66-79 years). Positive cases involving those under the age of 18 were found to account for 5.22% (n = 22) of the total. The highest positivity rate was observed in April 2021 at 8.28% of all test requests, while the lowest positivity rate was observed in June 2021, at 0.36% of all test requests. The highest positivity rate of April was followed by March (5.07%), October (4.74%), and August (3.13%).
Conclusion:In conclusion, the COVID-19 RT-PCR positivity rate in the series was detected as 2.85% in preoperative patients over the oneyear period. Monthly positivity rates in screening results are consistent with the number of cases seen in the general population.
Objective: Bloodstream infections are the most common nosocomial infections and significant reasons for mortality and morbidity. Early diagnosis and treatment are of vital importance in terms of patient prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.